Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the interest coverage ratio high or low?
The interest coverage ratio of -1.54x is 79% above its 5-year average of -7.33x, near the high end of its 5-year range (-17.47x–0.72x).
78.40% above its 12-month average of -7.13x.
Reported quarterly interest coverage; no daily interpolation. Q2 FY2026 (2026-06-30): -16.25x.
INTEREST COVERAGE RATIO
-1.54x
INTEREST COVERAGE RATIO AVG TTM
-7.13x
INTEREST COVERAGE RATIO AVG 3Y
-4.85x
INTEREST COVERAGE RATIO AVG 5Y
-7.33x
INTEREST COVERAGE RATIO AVG 10Y
N/A
INTEREST COVERAGE RATIO AVG 15Y
N/A
INTEREST COVERAGE RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
+78.40%
CURRENT VS 3Y AVG
+68.25%
CURRENT VS 5Y AVG
+78.98%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-6.38x
median of 528 covered companies
CURRENT VS SECTOR MEDIAN
+75.84%
vs the sector median at left
Mirum Pharmaceuticals, Inc.
Market Cap
$4.83B
Interest Coverage Ratio
-1.54x
TTM Avg
-7.13x
3Y Avg
-4.85x
5Y Avg
-7.33x
Market Cap
$4.84B
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$4.78B
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$4.73B
Interest Coverage Ratio
-30.34x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$4.70B
Interest Coverage Ratio
2.07x
TTM Avg
2.07x
3Y Avg
2.07x
5Y Avg
1.38x
Market Cap
$4.64B
Interest Coverage Ratio
5.35x
TTM Avg
5.33x
3Y Avg
5.03x
5Y Avg
4.13x
Market Cap
$5.06B
Interest Coverage Ratio
3.22x
TTM Avg
2.04x
3Y Avg
1.33x
5Y Avg
1.16x
Market Cap
$4.60B
Interest Coverage Ratio
168.66x
TTM Avg
168.66x
3Y Avg
168.66x
5Y Avg
168.66x
| NAME | MARKET CAP | INTEREST COVERAGE RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Mirum Pharmaceuticals, Inc. (MIRM) | $4.83B | -1.54x | -7.13x | -4.85x | -7.33x |
| Oruka Therapeutics, Inc. (ORKA)vs › | $4.84B | N/A | N/A | N/A | N/A |
| Dianthus Therapeutics, Inc. (DNTH)vs › | $4.78B | N/A | N/A | N/A | N/A |
| Definium Therapeutics, Inc. (DFTX)vs › | $4.73B | -30.34x | N/A | N/A | N/A |
| Erasca, Inc. (ERAS)vs › | $4.96B | N/A | N/A | N/A | N/A |
| LifeStance Health Group, Inc. (LFST)vs › | $4.70B | 2.07x | 2.07x | 2.07x | 1.38x |
| Option Care Health, Inc. (OPCH)vs › | $4.64B | 5.35x | 5.33x | 5.03x | 4.13x |
| Waystar Holding Corp. (WAY)vs › | $5.06B | 3.22x | 2.04x | 1.33x | 1.16x |
| BillionToOne, Inc. (BLLN)vs › | $4.60B | 168.66x | 168.66x | 168.66x | 168.66x |
| Merit Medical Systems, Inc. (MMSI)vs › | $5.07B | 6.97x | 5.98x | 8.44x | 9.07x |
Interest Coverage
-1.5x
Debt/Equity
N/A
Current Ratio
2.86
Formula: Interest Coverage = EBIT / Interest Expense
Reference ranges:
Note: Interest coverage should be compared with historical interest expense, operating income, and industry capital structure.
Interest Coverage = EBIT / Interest Expense
The interest coverage ratio measures operating earnings relative to interest expense.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | INTEREST COVERAGE RATIO |
|---|---|
| 2026-06-30 | -16.25x |
| 2026-03-31 | -17.47x |
| 2025-12-31 | -1.27x |
| 2025-09-30 | 0.72x |
| 2025-06-30 | -1.39x |
| 2025-03-31 | -4.22x |
| 2024-12-31 | -6.77x |
| 2024-09-30 | -3.54x |
| 2024-06-30 | -6.79x |
| 2024-03-31 | -7.40x |
| 2023-12-31 | -9.15x |
| 2023-09-30 | -7.04x |
| 2023-06-30 | -6.51x |
| 2023-03-31 | -6.40x |
| 2022-12-31 | -7.84x |
| 2022-09-30 | -8.28x |
| 2022-06-30 | -8.11x |
| 2022-03-31 | -8.67x |
| 2021-12-31 | -12.10x |
| 2021-09-30 | -7.56x |
| 2021-06-30 | -7.83x |
| 2021-03-31 | -14.08x |
| 2020-12-31 | -110.30x |
| 2019-03-31 | -1236.80x |
| 2018-09-30 | -32.50x |
